Your browser doesn't support javascript.
loading
Reactions and their management.
J Indian Med Assoc ; 2004 Dec; 102(12): 688-90, 692, 694
Article in English | IMSEAR | ID: sea-99955
ABSTRACT
The uneventful response to chemotherapy in leprosy is marked by clinically disturbing episodes encountered in 20-30% of patients and these phenomena are called "reactions". Generally they are classified as reversal reaction (type-1) and erythema nodosum leprosum (type-2). The cutaneous menifestations are (1) Type-2 reactions in LL, BL types constituting erythema nodosum leprosum, erythema multiforme, erythema necroticans, subcutaneous nodules, lepromatous exacerbation. (2) Type-1 reactions in borderline and tuberculoid leprosy. The other manifestations include Acute neuritis, lymphadenitis, arthritis, oedema of the hands and feet, ocular lesions, etc. Sequelae of reactions are Paralytic deformities, non-paralytic deformities, extensive scarring and renal damage. A simple guideline to identify the risk-prone cases has been narrated. Prednisolone in standard dosage schedule as recommended by WHO is now being widely used in control programmes.
Subject(s)
Full text: Available Index: IMSEAR (South-East Asia) Main subject: Paralysis / Arthritis / Skin / Thalidomide / Humans / Prednisolone / Cicatrix / Treatment Outcome / Clofazimine / Dose-Response Relationship, Drug Type of study: Practice guideline Language: English Journal: J Indian Med Assoc Year: 2004 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: IMSEAR (South-East Asia) Main subject: Paralysis / Arthritis / Skin / Thalidomide / Humans / Prednisolone / Cicatrix / Treatment Outcome / Clofazimine / Dose-Response Relationship, Drug Type of study: Practice guideline Language: English Journal: J Indian Med Assoc Year: 2004 Type: Article